Brachytherapy: Where Has It Gone...Again? CORRESPONDENCE
mande Jin-Xiong She Molecular biomarkers that can predict survival and therapeutic outcome are still lacking for cervical cancer. Here we measured a panel of 19 serum proteins in sera from 565 patients with stage II or III cervical cancer and identified 10 proteins that have an impact on disease specific survival (DSS) (Hazzard’s ratio; HR = 1.51–2.1). Surprisingly, all ten proteins are implicated in senescence-associated secreted phenotype (SASP), a hallmark of cellular senescence. Machine learning using Ridge regression of these SASP proteins can robustly stratify patients with high SASP, which ...
The aim of this work was to analyze the exposure rates measured in the proximity of patients who underwent prostate low-dose-rate brachytherapy with I-125 implant. Effective doses to relatives and to population were computed to estimate the time to reach radioprotection dose constraints.
Surgery, external beam radiotherapy (EBRT), and interventional radiotherapy (IRT, BrachyTherapy BT) are the current therapeutic options for nose vestibule (NV) squamous cell carcinoma (SCC). In this article, we evaluate the nose functional parameters of patients affected by SCCs of the NV, primarily treated by interstitial IRT comparing them with healthy controls and with patients treated with intensity-modulated EBRT.
We evaluated the use of ultrasound imaging within a brachytherapy applicator as a method for applicator positioning, evaluation, and treatment planning in a series of in vitro, cadaver, and human studies.
Conditions: 106 Ruthenium Plaque Brachytherapy; Uveal Melanoma Intervention: Radiation: 106 Ruthenium plaque brachytherapy Sponsor: Federico II University Completed
High dose-rate (HDR) brachytherapy (BT) is commonly used to treat prostate and cervical cancer by irradiating the target volume using dedicated applicators and/or catheters. BT offers sharp dose gradients which may lead to decreased dose to organs at risk compared to external beam radiotherapy.[1,2] Image-guided implant reconstruction has become standard practice, using medical imaging such as CT, MR or ultrasound acquired before treatment planning.[3,4] After reconstructing the applicator and/or interstitial catheters, a treatment plan is created using the target and organ at risk delineations by optimizing dwell times in...
Publication date: Available online 5 October 2020Source: Diagnostic and Interventional ImagingAuthor(s): M. Martin, A. Hocquelet, F. Debordeaux, L. Bordenave, J.-F. Blanc, P. Papadopoulos, B. Lapuyade, H. Trillaud, J.-B. Pinaquy
Radiation therapy firm Advanced Radiation Therapy (ART) has introduced its...Read more on AuntMinnie.comRelated Reading: Advanced Radiation Therapy names new CCO ART installs breast system in Fla. Advanced Radiation Therapy gets AccuBoost Digital sale Advanced Radiation Therapy upgrades AccuBoost in RI AccuBoost debuts product upgrades at ASTRO 2019
Publication date: Available online 6 October 2020Source: Journal of Minimally Invasive GynecologyAuthor(s): Pierre-Emmanuel Colombo, Van-Ha Nguyen, Christophe Taoum, Anne Mourregot, Mathias Neron, Christine Kerr, Philippe Rouanet, Guillaume Carrier
Abstract A new high dose rate (HDR) brachytherapy program was initiated in a community hospital setting, with the goal of using magnetic resonance (MR) images with the implant in place during the planning process. Physics acceptance testing and commissioning was completed for key program components, including multiple applicators. To image new applicators for MRI-based planning prior to use with patients, agar gel doped with copper sulfate was created using simple, MR-safe household materials as a practical and inexpensive alternative to custom-machined precision phantoms. Applicators in-phantom were scanned in a ...